Amar Ahmad

Amar Ahmad

Auto-generated profile, based on publicly available information

Amar Ahmad

Public Health Research Center, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NVNataša Vasiljević
Nataša Vasiljević
AAAmar S Ahmad
Amar S Ahmad
MTMangesh A Thorat
Mangesh A Thorat
GFGabrielle Fisher
Gabrielle Fisher
DBDaniel M Berney
Daniel M Berney
ALAttila T. Lorincz
Attila T. Lorincz
Prostate cancer has a variable clinical behaviour with frequently unpredictable outcome. DNA methylation plays an important role in determining the biology of cancer but prognostic information is scanty. We assessed the potential of gene-specific DNA methylation changes to predict death from prostate cancer in a cohort of untreated men in the UK. This was a population-based study in which cases were identified from six cancer registries in Great Britain. DNA was extracted from formalin-fixed paraffin wax-embedded transurethral prostate resection tissues collected during 1990-96 from men with clinically-localised cancer who chose not to be treated for at least 6 months following diagnosis. The primary end point was death from prostate cancer. Outcomes were determined through medical records and cancer registry records. Pyrosequencing was used to quantify methylation in 13 candidate genes with established or suggested roles in cancer. Univariate and multivariate Cox models were used to identify possible predictors for prostate cancer-related death. Of 367 men, 99 died from prostate cancer during a median of 9.5 years follow-up (max = 20). Univariately, 12 genes were significantly associated with prostate cancer mortality, hazard ratios ranged between 1.09 and 1.28 per decile increase in methylation. Stepwise Cox regression modelling suggested that the methylation of genes HSPB1, CCND2 and DPYS contributed objective prognostic information to Gleason score and PSA with respect to cancer-related death during follow-up (p = 0.006). Methylation of 13 genes was analysed in 367 men with localised prostate cancer who were conservatively treated and stratified with respect to death from prostate cancer and those who survived or died of other causes. Of the 13 genes analysed, differential methylation of HSPB1, CCND2 and DPYS provided independent prognostic information. Assessment of gene-methylation may provide independent objective information that can be used to segregate prostate cancers at diagnosis into predicted behavioural groups.

8 January 2026 in Frontiers in Big Data
Verified
Journal Article
Open access
PDF file
AAAmar Ahmad
Amar Ahmad
YVYvonne Vallès
Yvonne Vallès
YIYoussef Idaghdour
Youssef Idaghdour
Artificial Intelligence (AI) systems are increasingly embedded in high-stakes decision-making across domains such as healthcare, finance, criminal justice, and employment. Evidence has been accumulated showing that these systems can reproduce and amplify structural inequities, leading to ethical, social, and technical concerns. In this review, formal mathematical definitions of bias are integrated with socio-technical perspectives to examine its origins, manifestations, and impacts. Bias is categorized into four interrelated families: historical/representational, selection/measurement, algorithmic/optimization, and feedback/emergent, and its operation is illustrated through case studies in facial recognition, large language models, credit scoring, healthcare, employment, and criminal justice. Current mitigation strategies are critically evaluated, including dataset diversification, fairness-aware modeling, post-deployment auditing, regulatory frameworks, and participatory design. An integrated framework is proposed in which statistical diagnostics are coupled with governance mechanisms to enable bias mitigation across the entire AI lifecycle. By bridging technical precision with sociological insight, guidance is offered for the development of AI systems that are equitable, accountable, and responsive to the needs of diverse populations.

31 August 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
WAWafa Alnakhi
Wafa Alnakhi
HMHeba Mohammed Mamdouh
Heba Mohammed Mamdouh
HHHamid Y. Hussain
Hamid Y. Hussain
GIGamal M. Ibrahim
Gamal M. Ibrahim
AAAmar Sabri Ahmad
Amar Sabri Ahmad
AAAbdishakur Abdulle
Abdishakur Abdulle
Background: Non-communicable diseases (NCDs) are the leading causes of death worldwide. In the UAE, NCDs account for nearly 77% of all deaths. There is limited empirical research on this topic in the UAE. We aimed to examine the association of non-communicable diseases and the sociodemographic characteristics among the adult population of Dubai. Methods: The study used secondary data from the Dubai Household Health Survey (DHHS), 2019. DHHS is a cross-sectional complex design, stratified by geographic area, and uses multistage probability sampling. In this survey, 2247 families were interviewed and only adults aged 18+ were included for the analysis. The quasi-binomial distribution was used to identify the socio-demographic characteristics association with NCDs. Results: The prevalence of NCDs among the adult population of Dubai was 15.01%. Individuals aged 60+, local Arabs (Emirati), divorced and widowed individuals, and individuals who were not currently working reported NCDs more than the other groups. In the regression analysis, the association with NCDs were reported among elderly people, males, unmarried individuals, older individuals who are unmarried, and Emiratis. Conclusion: The study identified several socio-demographic characteristics associated with reporting NCDs. This is one of the few studies related to NCDs in Dubai. Allocating appropriate resources to the population groups identified is crucial to reduce the incidence of NCDs in the Emirate.

19 January 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Jacek MarzecJacek Marzec
Jacek Marzec
HRHelen Ross-Adams
Helen Ross-Adams
SPStefano Pirro
Stefano Pirro
JWJun Wang
Jun Wang
YZYanan Zhu
Yanan Zhu
Claude ChelalaClaude Chelala
Claude Chelala
Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.

FMFatima Mezhal
Fatima Mezhal
AAAmar Ahmad
Amar Ahmad
AAAbdishakur Abdulle
Abdishakur Abdulle
ALAndrea Leinberger-Jabari
Andrea Leinberger-Jabari
AOAbderrahim Oulhaj
Abderrahim Oulhaj
RARaghib Ali
Raghib Ali
Introduction: Metabolic syndrome (MetS) is a multiplex of risk factors that predispose people to the development of diabetes and cardiovascular disease (CVD), two of the major non-communicable diseases that contribute to mortality in the United Arab Emirates (UAE). MetS guidelines require the testing of fasting samples, but there are evidence-based suggestions that non-fasting samples are also reliable for CVD-related screening measures. In this study, we aimed to estimate MetS and its components in a sample of young Emiratis using HbA1c as another glycemic marker. We also aimed to estimate the associations of some known CVD risk factors with MetS in our population. Methods: The study was based on a cross-sectional analysis of baseline data of 5161 participants from the UAE Healthy Future Study (UAEHFS). MetS was identified using the NCEP ATP III criteria, with the addition of HbA1c as another glycemic indicator. Fasting blood glucose (FBG) and HbA1c were used either individually or combined to identify the glycemic component of MetS, based on the fasting status. Multivariate regression analysis was used to test for associations of selected social and behavioral factors with MetS. Results: Our sample included 3196 men and 1965 women below the age of 40 years. Only about 21% of the sample were fasting at the time of recruitment. The age-adjusted prevalence of MetS was estimated as 22.7% in males and 12.5% in females. MetS prevalence was not statistically different after substituting FBG by HbA1c in the fasting groups (p > 0.05). Age, increased body mass index (BMI), and family history of any metabolic abnormality and/or heart disease were consistently strongly associated with MetS. Conclusion: MetS is highly prevalent in our sample of young Emirati adults. Our data showed that HbA1c may be an acceptable tool to test for the glycemic component of MetS in non-fasting samples. We found that the most relevant risk factors for predicting the prevalence of MetS were age, BMI, and family history.

Nirmin F. JuberNirmin F. Juber
Nirmin F. Juber
AAAbdishakur Abdulle
Abdishakur Abdulle
AAAbdulla AlJunaibi
Abdulla AlJunaibi
AAAbdulla AlNaeemi
Abdulla AlNaeemi
AAAmar Ahmad
Amar Ahmad
RARaghib Ali
Raghib Ali
Limited studies have focused on maternal early-life risk factors and the later development of gestational diabetes mellitus (GDM). We aimed to estimate the GDM prevalence and examine the associations of maternal early-life risk factors, namely: maternal birthweight, parental smoking at birth, childhood urbanicity, ever-breastfed, parental education attainment, parental history of diabetes, childhood overall health, childhood body size, and childhood height, with later GDM. This was a retrospective cross-sectional study using the UAE Healthy Future Study (UAEHFS) baseline data (February 2016 to April 2022) on 702 ever-married women aged 18 to 67 years. We fitted a Poisson regression to estimate the risk ratio (RR) for later GDM and its 95% confidence interval (CI). The GDM prevalence was 5.1%. In the fully adjusted model, females with low birthweight were four times more likely (RR 4.04, 95% CI 1.36–12.0) and females with a parental history of diabetes were nearly three times more likely (RR 2.86, 95% CI 1.10–7.43) to report later GDM. In conclusion, maternal birthweight and parental history of diabetes were significantly associated with later GDM. Close glucose monitoring during pregnancy among females with either a low birth weight and/or parental history of diabetes might help to prevent GDM among this high-risk group.